Vision Disorders Eye Conditions Eye Diseases Eye Health Vision Correction Retinal Diseases Eye Care Eye Injuries Vision Restoration Age-related Macular Degeneration Patient Care Eye Surgery Myopia Glaucoma Vision Impairment Gene Therapy Symptoms Eye Care Services Diabetic Eye Disease Eyecare Products Eye Treatments Vision Loss Corneal Health Patient Education Surgical Interventions ICD-10 Coding Vitreous Floaters Intraocular Lenses Personal Preferences Imaging Technology Preventive Care Eye Infections Environmental Factors Ophthalmic Products Myths and Misconceptions Diabetic Retinopathy Infectious Diseases AMD Treatments Treatment Treatment Methods Diagnostic Technology Corneal Science Eye diseases Presbyopia Surgery Vision Problems Cataracts Innovative Treatments Refraction Errors Eye Drops Professional Societies Treatments Corneal Transplantation Retina Specialists Lens Types Vision Care Vitreous Humor Keratoconus Common Eye Diseases Surgical Techniques Child Health Public vs Private Eye Care Vision Health Macular Degeneration Treatment Options Age-related Conditions Emergency Services Ophthalmologists Retinal Conditions Treatment Innovations Waiting Lists Glaucoma Treatment Retinal Disorders Research Gender Disparities Gender Equity Refractive Surgery Appointment Management Corneal Diseases Clinical Practice Innovation Education Corneal Treatments Innovative Therapies Dry Eye Treatments Ocular Conditions Postoperative Care Virtual Clinics Corneal Disorders Medications Optic Nerve Damage Refractive Errors Eye Irritation Vitreous Opacities Visual Impairments
The company plans to file for approval in the first half of 2026 after a two-year, placebo-controlled study met its main goal.